Nurse Practitioner · Pittsburgh, PA
NPI
1265768329
Since 2009
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1515 Locust St, 5th Floor
Pittsburgh, PA, 15219
Phone (412) 281-3828
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,333
135 services
Medicare patients, 2024
86
Average age 74
Drug cost, 2024
$5.9M
916 prescriptions
Company payments, 2025
$4,708
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Genise Green was code 99215 (office e&m - established), 42 times for 41 patients. In total Genise Green billed 135 services in 8 codes, and Medicare paid $9,333.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 42 | 41 | $83.70 | $3,515 |
| 99443 Telephone Services | Office | 19 | 13 | $78.47 | $1,491 |
| 99214 Office E&M - Established | Facility | 17 | 17 | $58.82 | $1,000 |
By year: 2022 $3,158 for 40 services; 2023 $5,443 for 81 services; 2024 $9,333 for 135 services.
Medicare prescription drug claims, 2024
In 2024, the drug Genise Green prescribed most often to Medicare patients was Vyndamax (Tafamidis), with 191 prescriptions and refills. In total Genise Green wrote 916 Medicare prescriptions that cost $5.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vyndamax Tafamidis | 191 | 191 | 23 | $4.3M |
| Camzyos Mavacamten | 145 | 145 | 28 | $1.2M |
| Jardiance Empagliflozin | 58 | 90 | 15 | $51K |
| Spironolactone Generic | 54 | 71 | 15 | $417 |
| Eliquis Apixaban | 53 | 97 | 11 | $51K |
| Torsemide Generic | 47 | 93 | 13 | $705 |
| Disopyramide Phosphate Generic | 35 | 47 | Under 11 | $7,897 |
| Potassium Chloride Generic | 31 | 51 | Under 11 | $1,047 |
| Metoprolol Succinate Generic | 31 | 81 | 12 | $333 |
| Furosemide Generic | 29 | 85 | 14 | $356 |
| Metoprolol Tartrate Generic | 23 | 31 | Under 11 | $237 |
| Amlodipine Besylate Generic | 14 | 28 | Under 11 | $29.01 |
| Bumetanide Generic | 14 | 24 | Under 11 | $472 |
| Vyndaqel Tafamidis Meglumine | 13 | 13 | Under 11 | $301K |
| Farxiga Dapagliflozin Propanediol | 12 | 16 | Under 11 | $9,220 |
Brand drugs: 516 claims; generic drugs: 400 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Genise Green $4,708 ($4,708 in general payments such as food, travel and fees) from 5 companies. The largest payer was Alnylam Pharmaceuticals Inc. with $2,954.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.